Side Meetings


From historical insights to crystal balling the future: Preparing models for a new generation of challenges


  • 09:00 - 12:30 HRS. (BKK)

  • Venue : Lotus Suite 11

  • Contact Person : Saudamini Dabak,

  • Health Intervention and Technology Assessment Program (HITAP)
  • National University of Singapore (NUS)
  • London School of Hygiene and Tropical Medicine (LSHTM)
  • Bill & Melinda Gates Foundation (BMGF)
  • United Nations Development Programme (UNDP)
  • Ministry of Public Health (MOPH) Thailand
  • The Lancet

In this globalised world, feeling the cross-country and multi-sectoral impact of crises has become a norm. As it relates to emerging and pandemic infectious diseases, the world heavily relies on modern tools including the use of epidemiological modelling to help prevent, manage, and exit crises. However, these modelling tools are by no means perfect and suffer from several deficiencies surrounding the policy process, technical capabilities, communication, adhering to standards, capacity, among others. 


PMAC 2024 presents an avenue for multidiscplinary experts and stakeholders to come together to discuss global issues, available tools to address those issues, challenges in their effective use, and ways to overcome them, for the greater good. 


In this side meeting, experts will ponder on past expereinces before cystral balling future issues that we may have to adapt and address. The session will end with key messages from an ongoing Lancet Commission that aims to strengthen the use of epidemiological modelling of emerging and pandemic infectious diseases from policy, technical, and communications perspective. 


Recent commentary on the Commission:

The Commission webpage:


This Lancet Commission is being supported by the Bill & Melinda Gates Foundation, the United Nations Development Programme (UNDP), and the Ministry of Public Health (MOPH), Thailand.  

  • To reflect on how different countries used modelling to address the COVID-19 pandemic;
  • To discuss potential unforeseeable issues the modelling community may have to address and adapt to; and
  • To seek feedback on key messages coming from the Lancet Commission on strengthening the use of epidemiological modelling of emerging and pandemic infectious diseases.